From Financial Modeling Prep: 2024-11-04 19:05:06

Medifast, Inc. (NYSE:MED) impressed investors with an EPS of $0.1029, beating expectations and showing resilience in the health and wellness industry. Its revenue of $140.2 million exceeded estimates, highlighting strong sales performance. Financially, MED’s current ratio of 3.11 and debt-to-equity ratio of 0.09 demonstrate a solid financial position, attracting attention from stakeholders.



Read more at Financial Modeling Prep:: Medifast, Inc. (NYSE:MED) Surpasses Market Expecta…